MNTA – In other words, progress on the M356 (Copaxone) program exceeded the company’s internal expectations and was awarded the highest possible task-related score (130%) under in the stated compensation formula. If this does not imply an M356 ANDA filing during 2008, then there must something wrong with the scoring system.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”